𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis

✍ Scribed by Kirsten D. Bentsen; Jens H. Henriksen; Flemming Bendtsen; Kim Hørslev-Petersen; Ib Lorenzen


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
724 KB
Volume
11
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Splanchnic and renal extraction of circulating aminoterminal propeptide of type III procollagen and related antigens were studied in 12 patients with normal liver function and in 19 patients with alcoholic cirrhosis during catheterization. Type III procollagen peptide in serum was measured in two assays: the Type III Procollagen Peptide Radioimmunoassay Kit, a new assay that selectively determines the intact propeptide (and larger type III propeptide-holding antigens) and the Type III procollagen Fab assay that measures both the intact propeptide and the smaller fragments that quantitatively dominate in serum. A significant decrease in the concentration of the intact propeptide between the artery and the hepatic vein was found in the group with normal liver function (p less than 0.01) and in patients with cirrhosis (p less than 0.01). In patients with cirrhosis, however, the splanchnic extraction ratio of the intact propeptide (median = 0.04, range = -0.03 to 0.16) was significantly lower than in patients with normal liver function (median = 0.17, range = 0.05 to 0.36, p less than 0.01). The concentration of the intact propeptide in the hepatic vein was positively correlated to hepatic pressure (n = 18, r = 0.51, p less than 0.05) and inversely correlated to indocyanine green clearance (n = 15, r = -0.61, p less than 0.05). No splanchnic extraction could be demonstrated in the Type III propeptide Fab assay. A significant renal extraction was found in the Fab assay, but not in Type III Procollagen Peptide Radioimmunoassay Kit.(ABSTRACT TRUNCATED AT 250 WORDS)


📜 SIMILAR VOLUMES


Endothelin-1 and -3 plasma concentration
✍ Alexander L. Gerbes; Søren Møller; Veit Gülberg; Jens H. Henriksen 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

Increased as well as decreased plasma concentrations of the endothelins, endogenous vasoactive peptides, have been reported in cirrhosis. This might be caused by alterations of hepatic or renal clearance or release. Therefore, the aim of the current study was to investigate the influence of splanchn

Long-term decrease in serum N-terminal p
✍ Takeaki Suou; Keiko Hosho; Yukihiro Kishimoto; Yasushi Horie; Hironaka Kawasaki 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

To evaluate the effect of interferon alfa (EN-a) on the hepatic extracellular matrix, we investigated the changes in serum N-terminal propeptide of type I11 procollagen during and after 4 months of INF-ru treatment in 178 treated and 45 nontreated patients with chronic hepatitis C. Serum pretreatmen

The N-Terminal Propeptide of Collagen Ty
✍ Alain Frei; Arthur Zimmermann; Kurt Weigand 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

To evaluate the diagnostic significance of the collagen Type I11 (Col 1-3) N-terminal propeptide of procollagen Type 111, with respect to activity and degree of liver fibrosis, Col 1-3 serum concentrations were measured in 11 1 patients with chronic liver diseases and in 60 patients were correlated

Long-Term Follow-Up of Serum N-Terminal
✍ Kurt Weigand; Pierre-Yves Zaugg; Alain Frei; Arthur Zimmermann 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

To evaluate the diagnostic and prognostic significance of the N-terminal propeptide of collagen Type III (Col 1-3) in chronic liver disease, the peptide level was measured in the serum of 4 patients with primary biliary cirrhosis, 5 with chronic persistent hepatitis, 12 with chronic active hepatitis

Serum type III procollagen peptide, type
✍ Yoshikazu Murawaki; Yujiro Ikuta; Masahiko Koda; Hironaka Kawasaki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

To assess the clinical value of serum biochemical markers, the aminoterminal peptide of type III procollagen, type IV collagen 7S domain, the central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases, as a marker of hepatic fibrosis, we measured these four serum markers in